MeiraGTx
is a New York-based biopharmaceutical company that researches and develops gene therapeutics for the treatment of patients with parkinsons disease... Read moreMeiraGTx
is a New York-based biopharmaceutical company that researches and develops gene therapeutics for the treatment of patients with parkinsons disease... Read more
News
Jul 15, 2026
Zacks
MeiraGTx: Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High?
Jul 07, 2026
BioPharma Dive
MeiraGTx: Oberland pours up to $400M into MeiraGTx eye gene therapies
Jun 05, 2026
Seeking Alpha
MeiraGTx: MeiraGTx Holdings plc (MGTX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
May 17, 2026
Yahoo
MeiraGTx: Here's What Analysts Are Forecasting For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its First-Quarter Results
May 14, 2026
Marketscreener
MeiraGTx: MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2026
May 14, 2026
Zacks
MeiraGTx: MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Lags Revenue Estimates
May 14, 2026
GlobeNewswire
Press Release: MeiraGTx : MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr 24, 2026
Americanbankingnews
MeiraGTx: HC Wainwright Has Negative Outlook for MeiraGTx Q1 Earnings
Apr 17, 2026
Eyewire News
MeiraGTx: MeiraGTx Announces the Acquisition of XLRP Therapy from J&J
Apr 16, 2026
Benzinga
MeiraGTx: Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson
MeiraGTx Competitors
1
2
3
4
5
6
7
8
9
10